Angers, February 29, 2008 - Today, Intervet received an official order
of the Department for Agriculture and Fishery, France, to supply
inactivated vaccine against Bluetongue, serotype 8.

Intervet is working intensively to supply the Bovilis BTV 8 vaccine to
France as soon as possible, to support the French government and
farming sector in its fight against this devastating disease.

As the global leader in the development and supply of vaccines to
support animal health and welfare, Intervet has been actively working
on this virus since its emergence in Northern Europe in 2006 and
developed a vaccine against Bluetongue serotype 8 in a very short time
to meet the urgent need as quickly as possible. Intervet already
received firm orders from the UK and the Netherlands. Intervet is
currently optimizing the production process and is doing the utmost to
speed up the first deliveries for mid-spring.

The vaccine has been developed for sheep and for cattle. While sheep
need to be vaccinated once, cattle will need two vaccinations. The
Bluetongue control strategy and vaccine purchase and supply are
defined by the national authorities.